MrSnapple, well done for being an investor with CUV, interesting time for you guys! Hey, one clarification, what do you mean by "I hope we have a chance of skipping the phase 3 trails and be approved by the FDA", are you talking about PAR? Do you mean MPS and the chance of a combined Phase 2/3 trial? It wouldnt be possible for PAR to skip a Phase 3 trial totally would it? I cant see that happening as OA for example isnt strictly a direct death causing disease (ruling out indirectly effect of current Opioid treatments etc). The only way I can figure out how we could 'skip' Phase 3 is if the TGA for example allow compassionate use (and perhaps the same equivalent body [FDA] in the US), but in any case we would still need to do a Phase 3 anyway albeit a reduced sample size and hopefully a fast tracked one.
Second question for you/others, what is involved to get European approval, am I correct in saying that CUV have been using their product over there for months now? Is the FDA/TGA equivalent process as rigorous there?
- Forums
- ASX - By Stock
- PAR -v- CUV
MrSnapple, well done for being an investor with CUV, interesting...
-
- There are more pages in this discussion • 121 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
23.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $80.45M |
Open | High | Low | Value | Volume |
23.5¢ | 23.8¢ | 23.0¢ | $90.62K | 386.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 146485 | 23.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.0¢ | 31548 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 153578 | 0.235 |
6 | 236207 | 0.230 |
3 | 32000 | 0.225 |
17 | 488527 | 0.220 |
6 | 98958 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.240 | 31548 | 7 |
0.245 | 29098 | 3 |
0.250 | 18443 | 2 |
0.255 | 22598 | 2 |
0.260 | 58362 | 1 |
Last trade - 11.52am 26/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online